- Home
- AMPL vs CERT Comparison
AMPL vs CERT Comparison
Compare AMPL & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AMPL | CERT |
|---|---|---|
| Founded | 2012 | 2008 |
| Country | United States | United States |
| Employees | 818 | N/A |
| Industry | EDP Services | Retail: Computer Software & Peripheral Equipment |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 803.7M | 860.9M |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | AMPL | CERT |
|---|---|---|
| Price | $6.10 | $4.48 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 10 |
| Target Price | ★ $13.42 | $11.67 |
| AVG Volume (30 Days) | 2.1M | ★ 2.9M |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 11.84 | ★ 87.50 |
| EPS | N/A | ★ N/A |
| Revenue | $343,214,000.00 | ★ $418,838,000.00 |
| Revenue This Year | $17.43 | $4.18 |
| Revenue Next Year | $14.16 | $5.39 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 14.68 | 8.75 |
| 52 Week Low | $5.51 | $4.59 |
| 52 Week High | $14.27 | $13.88 |
Technical Indicators
Market Signals| Indicator | AMPL | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 40.63 | 23.11 |
| Support Level | $5.71 | N/A |
| Resistance Level | $7.73 | $6.47 |
| Average True Range (ATR) | 0.39 | 0.34 |
| MACD | -0.14 | -0.18 |
| Stochastic Oscillator | 16.64 | 0.00 |
Price Performance
Historical ComparisonAbout AMPL Amplitude Inc.
Amplitude Inc is a Software company that provides a Digital Analytics Platform that helps companies analyze their customer behavior within digital products. The Company delivers its application over the Internet as a subscription service using a software-as-a-service (SaaS) model and also it offers customer support related to initial implementation setup, ongoing support services, and application training. The company generates revenue through selling subscriptions to the platform. The company derives a majority of its revenue from the United States, and also has its presence in Internationally.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.